Sign in
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Sunday, September 8, 2024
Sign in / Join
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Facebook
Instagram
Twitter
Vimeo
Youtube
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Search
LATEST ARTICLES
Pharmaceuticals
Lilly Warns of Fake Weight-loss Drugs
propharmanews
-
June 21, 2024
0
Johnson & Johnson €125M Plant Upgrade
propharmanews
-
June 21, 2024
0
Kansas Sues Pfizer Over Covid Vaccine Misrepresentation
propharmanews
-
June 21, 2024
0
Animal Health
How Bird Flu Has Benefited Moderna
propharmanews
-
June 19, 2024
0
Pharmaceuticals
AstraZeneca’s Imfinzi Plus Chemotherapy Approved for Endometrial Cancer
propharmanews
-
June 19, 2024
0
Pharmaceuticals
CEO Lars Fruergaard Jorgensen of Novo Nordisk to Testify Before US Senate
propharmanews
-
June 19, 2024
0
FDA Approves Merck Pneumonia Vaccine
propharmanews
-
June 18, 2024
0
Pharmaceuticals
Insights Into Eli Lilly’s Strategic Response to Weight Loss Drug Demand Surge
propharmanews
-
June 18, 2024
0
Pharmaceuticals
Bristol Myers Squibb & Future M&A’s
propharmanews
-
June 17, 2024
0
Pharmaceuticals
Big Week Awaits Merck, BMS, Sarepta, and More
propharmanews
-
June 17, 2024
0
1
...
6
7
8
...
17
Page 7 of 17
Most Popular
Regulatory Update — Week of Sept. 2, 2024
September 7, 2024
Judge orders J&J to pay Auris investors more than $1B for merger violations
September 7, 2024
Cloud moment – PharmaTimes
September 6, 2024
European Commission grants orphan drug designation for Vivet’s VTX-806
September 6, 2024
Load more
Recent Comments
AstraZeneca $20Bn Strategy - Pro Pharma News
on
Summit Therapeutics & AstraZeneca Shine at Major Cancer conference
China’s Generic Ozempic - Pro Pharma News
on
Ozempic’s Growing Generic Competition
Recent Comments